Loading…

The Long-Term Use of a Low-Phenylalanine Diet in Late-Treated Phenylketonuria: A Single Case Report

Background  When phenylketonuria (PKU) is not diagnosed and long‐term treatment commenced within the first few weeks of life, permanent brain damage will occur. There is some evidence to show that late diagnosed or untreated people with PKU who have severe challenging behaviours may benefit from a l...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied research in intellectual disabilities 2006-06, Vol.19 (2), p.173-178
Main Authors: Hewitt, Philippa, Cottle, Mandy, Coleman, Carol
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background  When phenylketonuria (PKU) is not diagnosed and long‐term treatment commenced within the first few weeks of life, permanent brain damage will occur. There is some evidence to show that late diagnosed or untreated people with PKU who have severe challenging behaviours may benefit from a low phenylalanine diet [Harper & Reid (1987)Journal of Mental Deficiency Research vol. 31, pp. 209–212; Hoskins et al. (1992)Journal of Intellectual Disability Research vol. 36, pp. 183–191; Baumeister & Baumeister (1998) Clinical Neuropharmacology vol. 21, pp. 18–27; Fitzgerald et al. (2000)Journal of Intellectual Disability Research vol. 44, pp. 53–59]. Method  In the light of this evidence, a woman with late‐diagnosed PKU was treated with a low‐phenylalanine diet in an attempt to reduce her severe challenging behaviour. Results  A reduction in challenging behaviours was observed when phenylalanine levels were maintained within a specific narrow range. Data are reported over a 2‐year period. A dramatic rise in severe challenging behaviour was noticed when her blood phenylalanine levels fell below a certain level. Conclusions  This case report suggests that blood phenylalanine levels need to be maintained within a specific range for maximum benefit.
ISSN:1360-2322
1468-3148
DOI:10.1111/j.1468-3148.2005.00257.x